These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 16621431)

  • 1. Comprehensive management of diffuse malignant peritoneal mesothelioma.
    Sugarbaker PH; Yan TD; Stuart OA; Yoo D
    Eur J Surg Oncol; 2006 Aug; 32(6):686-91. PubMed ID: 16621431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peritoneal mesothelioma treated by cytoreductive surgery and intraperitoneal hyperthermic chemotherapy: results of a prospective study.
    Brigand C; Monneuse O; Mohamed F; Sayag-Beaujard AC; Isaac S; Gilly FN; Glehen O
    Ann Surg Oncol; 2006 Mar; 13(3):405-12. PubMed ID: 16485159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffuse malignant peritoneal mesothelioma: long-term survival with complete cytoreductive surgery followed by hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Bertulli R; Hutanu I; Deraco M
    Eur J Cancer; 2013 Oct; 49(15):3140-8. PubMed ID: 23831335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneal mesothelioma treated by induction chemotherapy, cytoreductive surgery, and intraperitoneal hyperthermic perfusion.
    Deraco M; Casali P; Inglese MG; Baratti D; Pennacchioli E; Bertulli R; Kusamura S
    J Surg Oncol; 2003 Jul; 83(3):147-53. PubMed ID: 12827682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
    Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
    Chua TC; Yan TD; Morris DL
    J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
    Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
    Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morbidity and mortality assessment of cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma--a prospective study of 70 consecutive cases.
    Yan TD; Edwards G; Alderman R; Marquardt CE; Sugarbaker PH
    Ann Surg Oncol; 2007 Feb; 14(2):515-25. PubMed ID: 17031722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of pseudomyxoma peritonei by cytoreduction+HIPEC (hyperthermic intraperitoneal chemotherapy): results analysis of a twelve-year experience.
    Vaira M; Cioppa T; DE Marco G; Bing C; D'Amico S; D'Alessandro M; Fiorentini G; DE Simone M
    In Vivo; 2009; 23(4):639-44. PubMed ID: 19567401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of factors associated with outcome in patients with malignant peritoneal mesothelioma undergoing surgical debulking and intraperitoneal chemotherapy.
    Feldman AL; Libutti SK; Pingpank JF; Bartlett DL; Beresnev TH; Mavroukakis SM; Steinberg SM; Liewehr DJ; Kleiner DE; Alexander HR
    J Clin Oncol; 2003 Dec; 21(24):4560-7. PubMed ID: 14673042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastases in diffuse malignant peritoneal mesothelioma.
    Baratti D; Kusamura S; Cabras AD; Laterza B; Balestra MR; Deraco M
    Ann Surg Oncol; 2010 Jan; 17(1):45-53. PubMed ID: 19856030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of treatment of 33 patients with peritoneal mesothelioma.
    Sebbag G; Yan H; Shmookler BM; Chang D; Sugarbaker PH
    Br J Surg; 2000 Nov; 87(11):1587-93. PubMed ID: 11091251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma.
    Saxena A; Chua TC
    Lung Cancer; 2009 Nov; 66(2):269-70. PubMed ID: 19733416
    [No Abstract]   [Full Text] [Related]  

  • 14. Combined resection, intraperitoneal chemotherapy, and whole abdominal radiation for the treatment of malignant peritoneal mesothelioma.
    Hesdorffer ME; Chabot JA; Keohan ML; Fountain K; Talbot S; Gabay M; Valentin C; Lee SM; Taub RN
    Am J Clin Oncol; 2008 Feb; 31(1):49-54. PubMed ID: 18376228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience.
    Yan TD; Deraco M; Baratti D; Kusamura S; Elias D; Glehen O; Gilly FN; Levine EA; Shen P; Mohamed F; Moran BJ; Morris DL; Chua TC; Piso P; Sugarbaker PH
    J Clin Oncol; 2009 Dec; 27(36):6237-42. PubMed ID: 19917862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicystic and well-differentiated papillary peritoneal mesothelioma treated by surgical cytoreduction and hyperthermic intra-peritoneal chemotherapy (HIPEC).
    Baratti D; Kusamura S; Nonaka D; Oliva GD; Laterza B; Deraco M
    Ann Surg Oncol; 2007 Oct; 14(10):2790-7. PubMed ID: 17661150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of lymph node metastasis in patients with diffuse malignant peritoneal mesothelioma.
    Yan TD; Yoo D; Sugarbaker PH
    Eur J Surg Oncol; 2006 Nov; 32(9):948-53. PubMed ID: 16806796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic indicators for patients undergoing cytoreductive surgery and perioperative intraperitoneal chemotherapy for diffuse malignant peritoneal mesothelioma.
    Yan TD; Brun EA; Cerruto CA; Haveric N; Chang D; Sugarbaker PH
    Ann Surg Oncol; 2007 Jan; 14(1):41-9. PubMed ID: 17039392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion: analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique.
    Kusamura S; Younan R; Baratti D; Costanzo P; Favaro M; Gavazzi C; Deraco M
    Cancer; 2006 Mar; 106(5):1144-53. PubMed ID: 16456817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
    Yano H; Moran BJ; Cecil TD; Murphy EM
    Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.